The global Aptamer Market is poised for accelerated growth, fueled by increasing interest in their use across diagnostic and therapeutic applications. Aptamers—short, single-stranded DNA or RNA molecules that bind selectively to various biological targets—have emerged as promising alternatives to antibodies due to their unique biochemical properties, cost-effectiveness, and broad...
The aptamer market has seen significant growth in recent years, with its applications in diagnostics, therapeutics, and research making it an attractive area for investment and innovation. Aptamers, short nucleic acid sequences that can bind to a variety of target molecules, offer several advantages over traditional antibodies, such as ease of synthesis, high stability, and low production...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)